A panel at the Centers for Disease Control and Prevention recommended the Pfizer-BioNTech coronavirus vaccine booster shots for people 65 years old and older, along with others at high risk of severe COVID-19.
The CDC’s Advisory Committee on Immunization Practices unanimously voted 15-0 to recommend booster shots for adults 65 and up. ACIP also voted 13-2 that individuals ages 50-64 with underlying health conditions should have access to the vaccine booster shot.
ACIP voted to approve the booster shot for individuals ages 18-49 with underlying conditions, so long as they take the shot six months after receiving both initial doses.
Members of the committee were concerned that data did not support the booster shot at younger ages. They stated that only marginal benefits would be achieved by giving the third shot.
The Food and Drug Administration approved the Pfizer booster for seniors and high-risk people on Wednesday
The announcement came after an advisory group serving the FDA overwhelmingly rejected a sweeping White House plan to dispense third shots to nearly everyone.